Page 32 - Molecular features of low-grade developmental brain tumours

1
30
CHAPTER 1
100, 498-500, doi:10.3171/ped.2004.100.5.0498 (2004).
147. Grajkowska, W. et al. Subependymal giant cell astrocytomas with atypical histological features
mimicking malignant gliomas. Folia Neuropathol 49, 39-46 (2011).
148. Buccoliero, A. M. et al. Subependymal giant cell astrocytoma (SEGA): Is it an astrocytoma?
Morphological, immunohistochemical and ultrastructural study. Neuropathology 29, 25-30,
doi:10.1111/j.1440-1789.2008.00934.x (2009).
149. Boer, K. et al. Inflammatory processes in cortical tubers and subependymal giant cell tumors of
tuberous sclerosis complex. Epilepsy Res 78, 7-21, doi:10.1016/j.eplepsyres.2007.10.002 (2008).
150. Lim, H. K. et al. Phosphatidic acid regulates systemic inflammatory responses by modulating the Akt-mammalian target of rapamycin-p70 S6 kinase 1 pathway. J Biol Chem 278, 45117-45127,
doi:10.1074/jbc.M303789200 (2003).
151. Curatolo, P. et al. Management of epilepsy associated with tuberous sclerosis complex: Updated
clinical recommendations. Eur J Paediatr Neurol 22, 738-748, doi:10.1016/j.ejpn.2018.05.006 (2018).
152. Chiron, C., Dumas, C., Jambaque, I., Mumford, J. & Dulac, O. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res 26, 389-395,
doi:10.1016/s0920-1211(96)01006-6 (1997).
153. Elterman, R. D., Shields, W. D., Mansfield, K. A., Nakagawa, J. & Group, U. S. I. S. V. S. Randomized trial
of vigabatrin in patients with infantile spasms. Neurology 57, 1416-1421, doi:10.1212/wnl.57.8.1416
(2001).
154. Cusmai, R., Moavero, R., Bombardieri, R., Vigevano, F. & Curatolo, P. Long-term neurological
outcome in children with early-onset epilepsy associated with tuberous sclerosis. Epilepsy Behav
22, 735-739, doi:10.1016/j.yebeh.2011.08.037 (2011).
155. Jozwiak, S. et al. Antiepileptic treatment before the onset of seizures reduces epilepsy severity and
risk of mental retardation in infants with tuberous sclerosis complex. Eur J Paediatr Neurol 15, 424-
431, doi:10.1016/j.ejpn.2011.03.010 (2011).
156. Bombardieri, R., Pinci, M., Moavero, R., Cerminara, C. & Curatolo, P. Early control of seizures
improves long-term outcome in children with tuberous sclerosis complex. Eur J Paediatr Neurol 14,
146-149, doi:10.1016/j.ejpn.2009.03.003 (2010).
157. Overwater, I. E. et al. Epilepsy in children with tuberous sclerosis complex: Chance of remission and
response to antiepileptic drugs. Epilepsia 56, 1239-1245, doi:10.1111/epi.13050 (2015).
158. Liang, S. et al. Long-term outcomes of epilepsy surgery in tuberous sclerosis complex. J Neurol 264,
1146-1154, doi:10.1007/s00415-017-8507-y (2017).
159. Fujiwara, H. et al. Resection of ictal high frequency oscillations is associated with favorable surgical
outcome in pediatric drug resistant epilepsy secondary to tuberous sclerosis complex. Epilepsy Res
126, 90-97, doi:10.1016/j.eplepsyres.2016.07.005 (2016).
160. Fallah, A. et al. Resective Epilepsy Surgery for Tuberous Sclerosis in Children: Determining Predictors
of Seizure Outcomes in a Multicenter Retrospective Cohort Study. Neurosurgery 77, 517-524;
discussion 524, doi:10.1227/NEU.0000000000000875 (2015).
161. Mohamed, A. R. et al. Intrinsic epileptogenicity of cortical tubers revealed by intracranial EEG
monitoring. Neurology 79, 2249-2257, doi:10.1212/WNL.0b013e3182768923 (2012).
162. Moshel, Y. A. et al. Do tubers contain function? Resection of epileptogenic foci in perirolandic cortex in children with tuberous sclerosis complex. Epilepsia 51, 1242-1251, doi:10.1111/j.1528-
1167.2009.02493.x (2010).
163. Major, P. et al. Are cortical tubers epileptogenic? Evidence from electrocorticography. Epilepsia 50,
147-154, doi:10.1111/j.1528-1167.2008.01814.x (2009).